TY - JOUR
AU - Erickson, Sharon
TI - HER2-Targeted Therapy Reduces Incidence and Progression of Midlife Mammary Tumors in Female Murine Mammary Tumor Virus huHER2-Transgenic Mice
JF - Cancer Epidemiology, Biomarkers and Prevention
DO - 10.1158/1078-0432.ccr-03-0448
DA - 2004-04-01
UR - https://www.deepdyve.com/lp/unpaywall/her2-targeted-therapy-reduces-incidence-and-progression-of-midlife-B29bPlBadm
DP - DeepDyve
ER -